Jump to content
IndiaDivine.org

Medicating Young Minds

Rate this topic


Guest guest

Recommended Posts

From AxisofLogic.com

 

Health/Medicine

: Drugs have become increasingly popular for treating

kids with mood and behavior problems. But how will

that affect them in the long run? Time, November 3,

2003 Issue

By Jeffrey Kluger

Oct 28, 2003, 08:42

 

 

 

 

Getting by is hard enough in middle school. it's

harder still when you've got other things on your

mind—and Andrea Okeson, 13, had plenty to distract

her. There were the constant stomach pains to

consider; there was the nervousness, the

distractibility, the overwhelming need to be alone.

And, of course, there was the business of repeatedly

checking the locks on the doors. All these things

grew, inexplicably, to consume Andrea, until by the

time she was through with the eighth grade, she seemed

pretty much through with everything else too.

" Andrea, " said a teacher to her one day, " you look

like death. "

 

 

 

The problem, though neither Andrea nor her teacher

knew it, was that her adolescent brain was being

tossed by the neurochemical storms of generalized

anxiety, obsessive-compulsive disorder (OCD) and

attention-deficit/hyperactivity disorder (ADHD)—a

decidedly lousy trifecta. If that was what eighth

grade was, ninth was unimaginable.

 

 

 

But that was then. Andrea, now 18, is a freshman at

the College of St. Catherine in St. Paul, Minn.,

enjoying her friends and her studies and looking

forward to a career in fashion merchandising, all

thanks to a bit of chemical stabilizing provided by a

pair of pills: Lexapro, an antidepressant, and

Adderall, a relatively new anti-ADHD drug. " I feel

excited about things, " Andrea says. " I feel like I got

me back. "

 

 

 

So a little medicine fixed what ailed a child. Good

news all around, right? Well, yes—and no. Lexapro is

the perfect answer for anxiety all right, provided

you're willing to overlook the fact that it does its

work by artificially manipulating the very chemicals

responsible for feeling and thought. Adderall is the

perfect answer for ADHD, provided you overlook the

fact that it's a stimulant like Dexedrine. Oh, yes,

you also have to overlook the fact that the Adderall

has left Andrea with such side effects as weight loss

and sleeplessness, and both drugs are being poured

into a young brain that has years to go before it's

finally fully formed. Still, says Andrea, " I'm just

glad there were things that could be done. "

 

 

 

Those things—whether Lexapro or Ritalin or Prozac or

something else—are being done for more and more

American children. In fact, they are being done with

such frequency that some people have justifiably begun

to ask, Are we raising Generation Rx?

 

 

 

Just a few years ago, psychologists couldn't say with

certainty that kids were even capable of suffering

from depression the same way adults do. Now, according

to PhRMA, a pharmaceutical trade group, up to 10% of

all American kids may suffer from some mental illness.

Perhaps twice that many have exhibited some symptoms

of depression.

 

 

 

Up to a million others may suffer from the alternately

depressive and manic mood swings of bipolar disorder

(BPD), one more condition that was thought until

recently to be an affliction of adults alone. ADHD

rates are exploding too. According to a Mayo Clinic

study, children between 5 and 19 have at least a 7.5%

chance of being found to have ADHD, which amounts to

nearly 5 million kids. Other children are receiving

diagnoses and medication for obsessive-compulsive

disorder, social-anxiety disorder, post-traumatic

stress disorder (PTSD), pathological impulsiveness,

sleeplessness, phobias and more.

 

 

 

Has the world—and American society in

particular—simply become a more destabilizing place in

which to raise children? Probably so. But other

factors are at work, including sharp-eyed parents and

doctors with a rising awareness of childhood mental

illness and what can be done for it. " While we don't

know exactly why the incidence of psychopathology is

increasing in children and adolescents, it probably

has to do with better diagnosis and detection, " says

Dr. Ronald Brown, professor of pediatrics at the

Medical University of South Carolina.

 

 

 

Also feeding the trend for more diagnoses is the

arrival of whole new classes of psychotropic drugs

with fewer side effects and greater efficacy than

earlier medications, particularly the selective

serotonin reuptake inhibitors (SSRIS), or

antidepressants. These have been rolled out with

highly visible, to-the-consumer ad campaigns.

 

 

 

While an earlier generation of

antidepressants—tricyclics like Tofranil—didn't work

in kids, SSRIS do. According to a study by Professor

Julie Zito of the University of Maryland School of

Pharmacy, use of antidepressants among children and

teens increased threefold between 1987 and 1996. And

that use continues to climb. Nobody, not even the drug

companies, argues that pills alone are the ideal

answer to mental illness. Most experts believe that

drugs are most effective when combined with talk

therapy or other counseling.

 

 

 

Nonetheless, the American Academy of Child and

Adolescent Psychiatry now lists dozens of medications

available for troubled kids, from the comparatively

familiar Ritalin (for ADHD) to Zoloft and Celexa (for

depression) to less familiar ones like Seroquel,

Tegretol, Depakote (for bipolar disorder), and more

are coming along all the time. There are stimulants,

mood stabilizers, sleep medications, antidepressants,

anticonvulsants, antipsychotics, antianxieties and

narrowcast drugs to deal with impulsiveness and

post-traumatic flashbacks. A few of the newest meds

were developed or approved specifically for kids. The

majority have been okayed for adults only, but are

being used " off label " for younger and younger

patients at children's menu doses. The practice is

common and perfectly legal but potentially risky. " We

know that kids are not just little adults, " says Dr.

David Fassler, professor of psychiatry at the

University of Vermont. " They metabolize medications

differently. "

 

 

 

Within the medical community—to say nothing of the

families of the troubled kids—concern is growing about

just what psychotropic drugs can do to still

developing brains. Few people deny that mind pills

help—ask the untold numbers who have climbed out of

depressive pits or shaken off bipolar fits thanks to

modern pharmacology. But few deny either that we're a

quick-fix culture, and if you give us a feel-good

answer to a complicated problem, we'll use it with

little thought of long-term consequences.

 

 

 

" The problem, " warns Dr. Glen Elliott, director of the

Langley Porter Psychiatric Institute's children's

center at the University of California, San Francisco,

" is that our usage has outstripped our knowledge base.

Let's face it, we're experimenting on these kids

without tracking the results. "

 

 

 

The Case For Medication

 

Those experiments, however, are often driven by dire

need. When a child is suffering or suicidal, is it

fair not to turn to the prescription pad in

conjunction with therapy? Is it even safe?

 

 

 

Untreated depression has a lifetime suicide rate of

15%—with still more deaths caused by related behaviors

like self-medicating with alcohol and drugs. Kids with

severe and untreated ADHD have been linked, according

to some studies, to higher rates of substance abuse,

dropping out of school and trouble with the law.

Bipolar kids have a tendency to injure and kill

themselves and others with uncontrolled behavior like

brawling or reckless driving. They are

 

 

 

Which is why Teresa Hatten of Fort Wayne, Ind.,

hesitated little when it came time to put her

granddaughter Monica on medication. Hatten's grown

daughter, Monica's mom, suffers from bipolar disorder,

and so does Monica, 13. To give Monica a chance at a

stable upbringing, Hatten took on the job of raising

her, and one of the first things she had to do was get

the violent mood swings of the bipolar disorder under

control. It's been a long, tough slog. An initial drug

combination of Ritalin and Prozac, prescribed when

Monica was 6, simply collapsed her alternating

depressed and manic moods into a single state with sad

and wild features. By the time she was 8, her behavior

was so unhinged, her school tried to expel her.

 

 

 

Next Monica was switched to Zyprexa, an antipsychotic,

that led to serious weight gain. " At 12 years old she

had stretch marks, " says Hatten. Now, a year later,

Monica is taking a four-drug cocktail that includes

Tegretol, an anticonvulsant, and Abilify, an

antipsychotic. That, at last, seems to have solved the

problem. " She's the best I've ever seen her, " says

Hatten. " She's smiling. Her moods are consistent. I'm

cautiously optimistic. " Monica agrees: " I'm in a

better mood. " Next up in the family's wellness

campaign: Monica's 8-year-old cousin Jamari, who is on

Zyprexa for a mood disorder. All along the disorder

spectrum there are such pharmacological success

stories. In the October issue of the Archives of

General Psychiatry, Dr. Mark Olfson of the New York

State Psychiatric Institute reports that every time

the use of antidepressants jumps 1%, suicide rates

among kids 10 to 19 decrease, although only slightly.

But that doesn't include the nonsuicidal depressed

kids whose misery is eased thanks to the same pills.

 

 

 

Are We Meddling With Normal Development?

 

For children with less severe problems—children who

are somber but not depressed, antsy but not clinically

hyperactive, who rely on some repetitive behaviors for

comfort but are not patently obsessive compulsive—the

pros and cons of using drugs are far less obvious.

" Unless there is careful assessment, we might start

medicating normal variations (in behavior), " says

Stephen Hinshaw, chairman of psychology at the

University of California, Berkeley.

 

 

 

The world would be a far less interesting place if all

the eccentric kids were medicated toward some golden

mean. Besides, there are just too many unanswered

questions about giving mind drugs to kids to feel

comfortable with ever broadening usage. What worries

some doctors is that if you medicate a child's

developing brain, you may be burning the village to

save it. What does any kind of psychopharmacological

meddling do, not just to brain chemistry but also to

the acquisition of emotional skills—when, for example,

antianxiety drugs are prescribed for a child who has

not yet acquired the experience of managing stress

without the meds? And what about side effects, from

weight gain to jitteriness to flattened

personality—all the things you don't want in the

social crucible of grade school and, worse, high

school.

 

 

 

Adding to the worries is a growing body of knowledge

showing just how incompletely formed a child's brain

truly is. " We now know from imaging studies that

frontal lobes, which are vital to executive functions

like managing feelings and thought, don't fully mature

until age 30, " says Hinshaw. That's a lot of time for

drugs to muck around with cerebral clay.

 

 

 

For that reason, it may not always be worth pulling

the pharmacological rip cord, particularly when

symptoms are relatively mild. Child psychologists

point out that often nonpharmaceutical treatments can

reduce or eliminate the need for drugs. Anxiety

disorders such as phobias can respond well to

behavioral therapy—in which patients are gently

exposed to graduated levels of the very things they

fear until the brain habituates to the escalating

risk.

 

 

 

 

 

 

 

 

 

Depression too may respond to new, streamlined therapy

techniques, especially cognitive therapy—a treatment

aimed at helping patients reframe their view of the

world so that setbacks and losses are put in less

catastrophic perspective. " The therapist teaches

relaxation skills and positive thinking, " says Denise

Chavira, clinical psychologist at the University of

California at San Diego. " It goes beyond talk

therapy. " Unfortunately, medical insurance pays more

readily for pills than these other treatments for

adults and children.

 

 

 

For kids with more serious symptoms, experts are

worried that undermedicating is a bigger risk than

overmedicating. " Say you've got a kid who's severely

obsessive and literally can't leave the home because

of the fears and rituals he's got to perform, " says

ucsf's Elliott. " Think about what anyone age 2 to age

16 has to learn to function in our society. Then think

about losing two of those years to a disorder. Which

two would you choose to lose? " Also on the side of

intervention is the belief that treating more kids

with mental illness could reduce its incidence in

adults.

 

 

 

Dr. Kiki Chang at Stanford University is trying to

show that this is true with bipolar kids. He recently

published a study in the Journal of Clinical

Psychiatry that looked at kids from bipolar families

who had only early signs of the disease. Pre-emptive

doses of Depakote eased early symptoms in 78% of cases

before the illness ever had a chance to take hold.

" You can sit and watch it develop or intervene and

possibly prevent the disorder, " says Chang. While the

researcher is excited about his results, he admits

that treating kids who are not yet truly sick is

controversial. " There's a chance some of the kids

might not develop bipolar at all, " says Chang. " We

need to have more genetics, more brain imaging, more

biological markers to know which direction the kids

are going. "

 

 

 

How Can We Measure the Result?

 

Preventing symptoms, of course, is not everything. A

sleeping child is completely asymptomatic, for

example, but that's not the same as being fully

functioning. If the drugs that extinguish symptoms

also alter the still developing brain, the cure may

come at too high a price, at least for kids who are

only mildly symptomatic. To determine if this kind of

damage is being done, investigators have been turning

more and more to brain scans such as magnetic

resonance imaging (MRI). The results they're getting

have been intriguing.

 

 

 

MRIs had already shown that the brain volumes of kids

with ADHD are 3% smaller than those of unafflicted

kids. That concerned researchers since nearly all

those scans had been taken of children already being

medicated for the disorder. Were the anatomical

differences there to begin with, or were they caused

by the drugs? Attempting to answer that, Dr. F. Xavier

Castellanos of the New York University Child Studies

Center took other scans, this time using only kids

with ADHD and comparing those who were taking

medication with those who were not. Reassuringly, he

discovered that they all shared the same structural

anomaly, a finding that seems to exonerate the drugs.

 

 

 

Dr. Steven Pliszka, chief of child psychiatry at the

University of Texas Health Center in San Antonio, went

further. He conducted scans that picked up not just

the structure but the activity of the brains of

untreated ADHD children, and compared these images

with those from children who had been medicated for a

year or more. The treated group showed no signs of any

deficits in brain function as measured in blood flow.

In fact, he says, " we saw hints of improvement toward

normal. "

 

 

 

The news was less positive when it came to bipolar

disorder. Chang has looked at the brains of kids

treated with Depakote, and while his study is as yet

unpublished, he says he noticed some anatomical

differences that could result from treatment—and he

wasn't necessarily happy with them. " We are seeing

that medications do affect the brain acutely, " he

says. " Is that a good thing, a bad thing? We just

don't know. "

 

 

 

What nobody denies is that more research is needed to

resolve all these questions—and that it won't be easy

to get it started. The first problem is one of time.

It was only in the early 1990s that the antidepressant

Prozac exploded into pharmacies. It's hard to do a

lifetime of longitudinal studies on a drug that's been

widely used for just over a decade. And each time the

industry invents a new medication, the clock rewinds

to zero for that particular pill.

 

 

 

 

 

 

 

 

 

Even if it were possible to conduct extended studies,

getting volunteers for the work is difficult. The

attrition rate is high in any years-long research,

especially so when the subjects are kids, who bore

easily and, at any rate, eventually go away to

college. On average, 40% of children will drop out of

a long-term study before the work is done. And that

assumes their parents will even sign them up in the

first place. Some brain scans involve at least a

little bit of radiation—something most parents are

reluctant to expose their children to, particularly if

those kids have no emotional disorders and are simply

being used as a baseline to establish the look of a

healthy brain. Getting good scans from kids who have

diagnosable conditions isn't easy, as any radiologist

who has ever tried to conduct a lengthy MRI on a child

with ADHD can attest. " Holding still is not exactly

what they do well, " says Elliott.

 

 

 

Ethical questions hamstring research too. Any

gold-standard study requires that some of the kids who

are suffering from a disorder receive no drugs so that

they can be compared with the kids who do. But if you

believe the medications are helpful, how can you

withhold them from a group of symptomatic children who

need them? Despite such obstacles, research is moving

ahead, if haltingly. The National Institute of Mental

Health is conducting a study called the Preschool ADHD

Treatment Study, in which researchers will track ADHD

kids between 3 and 8 years old to determine the

benefits and side effects of stimulant medications.

Castellanos and N.Y.U. colleague Rachel Klein are

taking things further, calling back subjects who were

enrolled in an ADHD-treatment study that began in 1970

to scan their now late-30s and early-40s brains for

the long-term effects of drugs. Castellanos is also

planning a study of young rats treated with varying

amounts of psychotropic drugs, conducting dosing and

anatomical studies that cannot be performed on humans.

 

 

 

 

The Risk of Hasty Prescriptions

 

Just as important as getting the research rolling is

fixing the health-care system kids rely on to get

well. Like adults taking mind meds, children often get

their drugs not from a specialist in psychiatry and

psychopharmacology but from any M.D. with the power of

the prescription pad. Usually this means the

pediatrician or family doctor, who isn't likely to

have the time or training necessary for the extensive

evaluations needed before drugs can be properly

prescribed—much less the required follow-up visits.

" There's no way you can screen for side effects in a

10-year-old in five minutes, " says Miami neurologist

Sara Dorison. " You have to chat about their summer,

their friends. "

 

 

 

Part of the reason for all the hurry-up drugging, say

psychiatrists, is managed care, which, already

disinclined to pay for longer, more costly talk

therapy, is equally reluctant to foot the bill to make

sure patients on pills are well monitored. In a

perfect—or at least better—world, says Elliott,

parents considering meds for their kids would have

access not to one specialist but three: a

pediatrician, a behavioral pediatrician and a

child-adolescent psychiatrist. " Insurance companies

talk about second opinions, " he says, " but they don't

actually like them. "

 

 

 

The pharmaceutical companies could be doing better

too—and if they don't, the government must push them

to do it. There is a lot of money to be made in

developing the next Prozac, but there is less profit

if you test it for longer than the law demands. The

Food and Drug Administration (FDA) doesn't require

long-term studies that follow patients over decades.

Its only requirement is toxicity trials that span six

to eight weeks. In an effort to entice companies to

conduct lengthier studies, the agency now grants an

extension of six months of exclusive marketing rights

to any company engaging in studies of a drug's effects

on a minimum of 100 children for more than six months.

" It's a relatively small amount of data, " acknowledges

Dr. Thomas Laughren, a psychiatrist with the FDA's

psychopharmacology division, " but it's better than

what we had before, which was nothing. "

 

 

 

Until all these things happen, the heaviest lifting

will, as always, be left to the family. Perhaps the

most powerful medicine a suffering child needs is the

educated instincts of a well-informed parent—one who

has taken the time to study up on all the

pharmaceutical and nonpharmaceutical options and pick

the right ones. There will always be dangers

associated with taking too many drugs—and also dangers

from taking too few. " Like every other choice you make

for your kids, " says Chang, " you make right ones and

wrong ones. " When the health of a child's mind is on

the line, getting it wrong is something that no parent

wants.

 

 

 

—With reporting by Dan Cray/Los Angeles, Alice

Park/New York, Kathie Klarreich/Miami, and Leslie

Whitaker/ Jefferson City

 

http://www.time.com/time/covers/1101031103/story.html

 

 

 

 

 

 

New Photos - easier uploading and sharing.

 

Link to comment
Share on other sites

> Those things—whether Lexapro or Ritalin or Prozac or

> something else—are being done for more and more

> American children. In fact, they are being done with

> such frequency that some people have justifiably begun

> to ask, Are we raising Generation Rx?

>

 

Dr. Abram Hoffer is an M.D. in Victoria Canada who has been

successfully treating depression, anxiety, insomnia, schizophrenia and

ADHD with vitamins and minerals,for over forty years. He was named " the

father of orthomolecular medicine " by Linus Pauling. He uses high-dose

niacin, extra b-6, b-complex, magnesium and trace elements. Here's an

article on it called, " Vitamin protocols reverse mental illness "

http://zeek.ca/4u/article.php?sid=149 & mode=threaded & order=0

 

Similarly, in this article " Aggressive behaviour linked to vitamin

deficiency " , vitamins and minerals were used against deficiencies that

cause behavioural problems.

http://zeek.ca/4u/article.php?sid=150 & mode=threaded & order=0

 

My point is, if the doctors don't first rule out nutritional deficiency

and toxin issues what the heck are they doing treating it like it's a

" drug deficiency " ?

 

Put another way, deficiencies and toxin issues can present a variety of

symptoms; as well as confounding an accurate diagnosis they will impede

healing progress. By first removing these obstacles, at least the

doctors will have something meaningful to treat that might require

their skill, if indeed there's anything left to treat at all.

 

We are in the middle of social change in that direction; many doctors

are embracing it, a few are being dragged into it kicking and

screaming. The leading-edge doctors are aware of these issues. The

trailing-ass doctors increasingly get fired by their patients.

 

Duncan Crow

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...